Medmix

Medmix's reported carbon emissions

Medmix, headquartered in Switzerland (CH), has reported its carbon emissions for the years 2022, 2023, and 2024. For **2024**, Medmix reported total emissions of approximately **73.59 million kg CO2e**. This comprises Scope 1 emissions of about 4.35 million kg CO2e, Scope 2 emissions of approximately 5.88 million kg CO2e, and Scope 3 emissions totalling around 63.36 million kg CO2e. In **2023**, the company's total emissions were approximately **65.59 million kg CO2e**. This included Scope 1 emissions of about 4.38 million kg CO2e, Scope 2 emissions of approximately 1.21 million kg CO2e, and Scope 3 emissions totalling around 60.04 million kg CO2e. For **2022**, Medmix's total emissions amounted to approximately **74.73 million kg CO2e**. This breakdown includes Scope 1 emissions of around 5.41 million kg CO2e, Scope 2 emissions of approximately 1.55 million kg CO2e, and Scope 3 emissions of about 67.80 million kg CO2e. Medmix has established significant climate commitments. The company has committed to reducing its absolute carbon footprint by **50% by 2030**, using 2019 as the base year. Furthermore, Medmix has set ambitious targets aligned with the Science Based Targets initiative (SBTi). They aim to reduce absolute Scope 1 and 2 GHG emissions by **80% by 2029**, also from a 2019 base year. Concurrently, they plan to reduce absolute Scope 3 GHG emissions by **42% by 2029**. Looking further ahead, Medmix has a long-term commitment to reduce absolute Scope 1, 2, and 3 GHG emissions by **90% by 2050** from the 2019 baseline, with an overarching goal to achieve net-zero greenhouse gas emissions across their value chain by 2050.